RNA-seq of AML cells with MPI KO and FLT3 tyrosine kinase inhibition

ABSTRACT: Molm13 AML cell line both control and MPI KO, treated with AC220 (quizartinib) and mannose at 24 and 72 hours after drug treatment. 2 reads and 2 repeats for each condition, 2 timepoints, 48 total files.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Keith Woodley 

PROVIDER: E-MTAB-11750 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress